CHI is offering a series of blog articles on the speakers who will be addressing families attending the Fourth Congenital Hyperinsulinism Family Conference March 17 and 18, 2012, in Philadelphia, PA. In this article, we present Dr Adda Grimberg.
In the 15 years I have been part of the HI family community issues relating to growth have been a common cause of parental anxiety. Whether the issues are related to weight, height, or puberty onset, families often worry about how the disorder, some of the medications, and/ or dietary regimes will affect the course of child development. With these concerns in mind, we decided to invite an endocrinologist specializing in growth issues to come to the Philadelphia conference to address the questions parents have. We are very lucky to have just the right expert to address these concerns.
Dr. Grimberg, an attending physician at the Children’s Hospital of Philadelphia (CHOP) has treated many children with HI and is a leading expert on growth. She is both a clinician and researcher. Dr. Grimberg treats endocrine patients at CHOP and she is the Scientific Director of the Diagnostic and Research Growth Center at CHOP, where approximately 80 new growth patients are referred for evaluation per month and approximately 2000 children per year are followed for growth issues.
Dr. Grimberg is also a leader at the Pediatric Endocrine Society in this field and has been appointed Chair of the taskforce charged with drafting the new guidelines for rhGH and rhIGF-I use in children and adolescents. Dr. Grimberg is a rare resource and we are very lucky she will be with us in Philadelphia.
